ERISMODEGIB: 39 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
39
Total FAERS Reports
10 (25.6%)
Deaths Reported
36
Hospitalizations
39
As Primary/Secondary Suspect
1
Life-Threatening
2
Disabilities
First Report: 20130321 · Latest Report: 20180814
What Are the Most Common ERISMODEGIB Side Effects?
#1 Most Reported
Sepsis
4 reports (10.3%)
#2 Most Reported
Febrile neutropenia
4 reports (10.3%)
#3 Most Reported
Death
4 reports (10.3%)
All ERISMODEGIB Side Effects by Frequency
No side effect data available.
Who Reports ERISMODEGIB Side Effects? Age & Gender Data
Gender: 55.6% female, 44.4% male. Average age: 60.9 years. Most reports from: NL. View detailed demographics →
Is ERISMODEGIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 3 | 1 | 3 |
| 2014 | 10 | 2 | 9 |
| 2015 | 11 | 1 | 11 |
| 2016 | 3 | 2 | 3 |
| 2017 | 6 | 1 | 6 |
| 2018 | 3 | 0 | 3 |
What Is ERISMODEGIB Used For?
| Indication | Reports |
|---|---|
| Pancreatic carcinoma | 10 |
| Myelodysplastic syndrome | 8 |
| Myelofibrosis | 7 |
Official FDA Label for ERISMODEGIB
Official prescribing information from the FDA-approved drug label.